Published in AIDS Weekly, June 3rd, 2002
The tampering could be dangerous, manufacturer GlaxoSmithKline warned May 10, 2002.
About 5% of people who take Ziagen can suffer potentially life-threatening allergic reactions - something patients thinking they were taking Combivir wouldn't have been warned about since that drug doesn't carry the same risk, the company said.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.